Thompson Siegel & Walmsley’s Bio-Techne TECH Stock Holding History

Thompson Siegel & Walmsley’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-76	Closed	-$2K	–	942
2016 Q4	$2K	Buy	+76	New	+$2K	﹤0.01%	787

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Siegel & Walmsley's TECH Position: Q1 2017 in Review

Thompson Siegel & Walmsley sold out of Bio-Techne (TECH) in Q1 2017, closing a stake of 76 shares — an estimated $2K sold.

Thompson Siegel & Walmsley first reported a position in TECH in Q4 2016 and held it in 1 quarter. The position peaked at $2K in Q4 2016. 271 funds tracked by Wall St. Rank hold TECH as of Q1 2017.

Thompson Siegel & Walmsley reported no remaining Bio-Techne position as of Q1 2017 after selling out during the quarter.
Thompson Siegel & Walmsley sold 76 Bio-Techne shares in Q1 2017, an estimated $2K.
Thompson Siegel & Walmsley first reported a position in Bio-Techne in Q4 2016 and held it in 1 quarter.
Thompson Siegel & Walmsley's Bio-Techne position peaked at $2K in Q4 2016.
271 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2017, filed 15 May 2017.